Good morning and more news:
Press Release Source: Medify Solutions Limited
Medify International Ltd to float Medify Asia
Tuesday May 16, 9:51 am ET
GATESHEAD, UK, May 16 /PRNewswire-FirstCall/ - Medify International Limited, a wholly owned subsidiary of Medify Solutions Limited (US), is to float a dedicated operation in the UAE.
Due to huge demand and interests in the Medify proposition, the International division of Medify Solutions Limited (US) and the Board decided that to maximise the opportunity granted to Medify in the UAE, the company would set up and float an operation based out of the UAE to manage and deliver its Asian business.
The company will be set up to deliver the Medify Suite of products and follow the same proven principles as demonstrated in the UK. This company will be used as the benchmark and gold standard for all future operations in the Global market place. This exciting development will allow Medify to take a lead in Global healthcare and set the standards.
The set up company, as with all others, will be a self financing and managing entity, reporting to the Board of Medify Solutions Limited (US). As with the Medify International float, all existing shareholders at the time of the float will receive a share for share dividend with the company being floated on the Dubai Board of Exchange.
Jonathan Bryant, Executive Chairman, said: "The continued demand and interest in the Medify proposition globally is immensely encouraging and significant. Again as a company we can not only deliver to our customers the proven benefits of MedfiyRemote, but we are enabled through their belief, to set up dedicated teams to deliver in situ in each and every country and continent. This demand not only allows us to ensure the success of our business globally, but it allows us to reward the patience and belief shown by those who invested in Medify Solutions Limited (US). As a company we have made significant steps forward in delivering the business in the UK, Italy and now the UAE which for our shareholders is not only good news, but directly results in increased shareholding, which to date is now 3 times any investment held from May 2006, at no additional cost. I truly believe the company is at the threshold of commercial success and the latest floatation announcement, from my perspective, has proven and justified the Board's decision to re-structure the company".
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
--------------------------------------------------------------------------------
Source: Medify Solutions Limited
